SARS-CoV-2 Spike RBD Antibody, R&D Systems™
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Spike RBD
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Host Species
Mouse
Purification Method
Protein A or G purified from hybridoma culture supernatant
Regulatory Status
RUO
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Isotype
IgG2a
Applications
Blocking Assay, Neutralization, Immunocytochemistry
Clone
1049621
Dilution
Blockade of Receptor-ligand Interaction, Neutralization, Immunocytochemistry 8-25 ug/mL
Gene Accession No.
P0DTC2
Immunogen
Human embryonic kidney cell, HEK293-derived SARS-CoV2 SARS-CoV2 spike, Arg319-Phe541, Accession # P0DTC2
Quantity
25 μg
Primary or Secondary
Primary
Target Species
SARS-CoV-2
Form
Purified
Related Products
Description
- Spike RBD Monoclonal antibody specifically detects Spike RBD in SARS-CoV-2 samples
- It is validated for Blocking Assay, Neutralization, Immunocytochemistry